12 HR Allergy & Congestion Relief Fexofenadine HCl
Failed dissolution specifications
1,058 recalls, newest first
Failed dissolution specifications
Failed dissolution specifications
Failed dissolution specifications
Failed dissolution specifications
Failed dissolution specifications
Failed dissolution specifications
Crystallization; identified as Buprenorphine free base
Defective Container: Customer complaints for leaking bottles and dispensing issues.
Superpotent Drug
Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide.
Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide.
Failed Impurities/Degradation Specifications
cGMP Deviations: Product manufactured with contaminated raw ingredient.
cGMP Deviations: Product manufactured with contaminated raw ingredient.
Crystallization: Product appears to be turbid.
Failed Impurities/Degradation Specifications
Labelling: Incorrect Exp. Date
CGMP Deviations: Other lots recalled because they were manufactured using common ingredients as the contaminated lot
CGMP Deviations: Other lots recalled because they were manufactured using common ingredients as the contaminated lot
Chemical Contamination: presence of benzene, acetaldehyde, and acetal.
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.
CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.